SBIR/STTR Research Award
DEVELOPMENT OF SKIN FLAP THERAPY DEVICE
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- COTTLER TECHNOLOGIES, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Verbatim From Applicant's Abstract):Development of a mechanical
skin flap therapy device is proposed for the removal of stagnated blood and
generation of blood flow within congested skin flaps to promote survival.
Venous congestion is defined as a patent arterial inflow with compromised
venous outflow in skin flaps, and has a 10 percent occurrence rate. Preliminary
data shows multiple mechanically made outlets are as effective as leeches in
alleviating venous congestion. With this data and an understanding of the
beneficial mechanisms of leech therapy, a micro-mechanical, disposable device
was designed to mimic these mechanisms while eliminating the drawbacks. The
device design comprises a self-contained vacuum pump, based upon an innovative
lightweight actuator, sharp outlets to puncture the skin and draw fluid from
the flap, and an on-board battery power supply. Optimizing the actuator to
maximize displacement while minimizing power is important to a successful
design. Such a device would be utilized clinically like a leech to alleviate
venous congestion and prophylactic treatments averting potential congestion.
Leeches are currently not applied for prophylaxis. the long-term goal is to
increase the success rate of skin flaps through commercial availability of this
micro-device for interventional fluid transport from congested flaps.
PROPOSED COMMERCIAL APPLICATION:
There are approximately 1,000,000 procedures performed in the United States that
potentially require the use of skin flaps. For treatment of venous congested flaps, over
70,000 leeches are currently sold to plastic surgery clinics annually, but they are only
utilized upon serious, advanced indications of venous congestion. With the development
of a small device that mimics the leech available off the shelf, that market could easily grow
to three times that amount (see pages MARKET RESEARCH discussion), while also
enhancing the overall success rate of skin flap transfer procedures. With the proposed
device, the existing drawbacks to leech therapy would be eliminated thus making the
mechanical leech a viable alternative in this market for patients, health care providers,
and insurance companies.
Technology keywords
Not reported